XIth Eurasian Hematology-Oncology Congress - EHOC 2020
CML Updates: Prognostic Factors, Conventional Drugs, 1L Therapy, Treatment Access/Monitoring, Resistance and 2L Therapy, Current Challenges in Developing Countries
Login to view comments.
Click here to Login